Highly active antiretroviral therapy-associated ptosis in patients with human immunodeficiency virus.
Silkiss
Rona Z
RZ
Lee
Han
H
Gills Ray
Vincent L
VL
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced* / Q000601:surgery; D002219:Carbamates / Q000009:adverse effects; D016049:Didanosine / Q000009:adverse effects; D015224:Dideoxynucleosides / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009801:Oculomotor Muscles / Q000601:surgery; D010755:Organophosphates / Q000009:adverse effects; D063065:Organophosphonates / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D000068698:Tenofovir; D000099227:Abacavir
D000225:Adenine; D019380:Anti-HIV Agents; D002219:Carbamates; D016049:Didanosine; D015224:Dideoxynucleosides; D005663:Furans; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D010755:Organophosphates; D063065:Organophosphonates; D013449:Sulfonamides; D000068698:Tenofovir; D000099227:Abacavir; C426859:fosamprenavir